IMMUNOLOGY2026
The IMMUNOLOGY2026 meeting, hosted by The American Association of Immunologists (AAI), is the leading annual all-immunology event worldwide, scheduled to take place from April 15 to 19, 2026, in Boston. […]
The IMMUNOLOGY2026 meeting, hosted by The American Association of Immunologists (AAI), is the leading annual all-immunology event worldwide, scheduled to take place from April 15 to 19, 2026, in Boston. […]
The 3rd Pediatric Exercise Oncology Congress (PEOC) meets FORTEe - themed "Bringing Together Evidence and Innovation in Pediatric Exercise Oncology" - is a two-day event scheduled for April 16-17, 2026, in Mainz, Germany. This congress is a collaborative effort between PEOC and the FORTEe network, bringing together clinicians, researchers, and stakeholders to focus on the […]
The Association of Cancer Physicians (ACP), currently transitioning to the UK Society for Medical Oncology (UKSMO), will host its 2026 Annual Conference from April 16–18 at the Crowne Plaza Hotel […]
The APPOS Richmond 2026: Advanced Practice Providers Oncology Summit will take place April 17–18, 2026, in Richmond, Virginia, USA. This two-day conference is designed for advanced practice providers—including nurse practitioners, […]
The APPOS Los Angeles 2026 (Advanced Practice Providers Oncology Summit) is a two-day conference designed for advanced practice providers (APPs) including NPs, PAs, pharmacists, and nurses, as well as the […]
The APPOS Minneapolis 2026 (Advanced Practice Providers Oncology Summit) is a two-day conference designed for advanced practice providers (APPs), including NPs, PAs, pharmacists, and nurses, as well as other oncology […]
The ESMO Summit Latin America 2026 is a premier educational meeting scheduled for April 17-18, 2026, in Bogotá, Colombia. Organized by the European Society for Medical Oncology (ESMO) in collaboration with the Colombian Association of Hematology and Oncology (ACHO), this two-day summit provides a comprehensive technical review of practice-changing clinical studies and international standards of […]
The AACR Annual Meeting 2026 will take place from April 17–22 at the San Diego Convention Center in California, bringing together the global cancer research community. Organized by the American […]
The ALRCaN Global webinar, “Effects of Race and Ethnicity on Hematopoietic Stem Cell Transplant Outcomes in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis,” is set for Friday, April 17, 2026, from 09:00 AM to 10:00 AM ET (05:00 PM – 06:00 PM AMT). Led by Dr. Anna M. Eiring, this session examines critical data […]
The 2nd National ICE-T (Immune Cell Effector Therapy) Congress is a specialized clinical conference focused on the latest advancements in cellular and bispecific therapies for hematologic and solid tumors. Scheduled for April 18, 2026, in Charlotte, North Carolina, the congress brings together oncologists, researchers, and nurses to discuss CAR-T innovations, the management of immune-related toxicities, […]
The 2026 Australian Pain Society 46th Annual Scientific Meeting (APS 2026) is Australia's leading multidisciplinary conference focused on the management and research of complex pain. The meeting is scheduled for […]
The 2026 World Indigenous Cancer Conference (W.I.C.C. 2026) is being hosted by the World Indigenous Cancer Network and Hei Āhuru Mōwai Māori (Cancer Leadership Aotearoa). The conference will be held […]
The 2026 World Indigenous Cancer Conference (WICC 2026) will be held from April 21 to 23, 2026, at Te Whare Tapere o Manukau (Due Drop Events Centre) in Auckland, New […]
NCCN will host a specialized tumor board session titled "Managing Unique Toxicities and Immune-Related Adverse Effects of Treatment for Hodgkin Lymphoma" on April 30, 2026, from 3:00 PM to 4:00 PM EDT. As the treatment paradigm for advanced classic Hodgkin lymphoma (cHL) shifts toward frontline antibody-drug conjugates and immune checkpoint inhibitors, clinicians must pivot from […]
The Lung Cancer Europe Conference 2026 is a dedicated advocacy and educational summit scheduled for April 22–24, 2026, in Vienna, Austria. This biennial event serves as a critical platform for […]
On April 22, 2026, NCCN will host a specialized clinical program titled "Optimizing Patient Outcomes - In a Blink of an Eye: Updates in Frontline Therapy with Blinatumomab for Pediatric Acute Lymphoblastic Leukemia." While pediatric ALL survival rates have improved significantly over decades, the integration of blinatumomab into upfront therapy for newly diagnosed B-cell ALL […]